---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-025182"
form_type: "8-K"
ticker: "QSI"
cik: "0001816431"
company_name: "Quantum-Si Inc"
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T06:46:11.807201+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Quantum-Si reports Q1 revenue $457K, net loss $19.5M; launches Platinum instrument

## Summary
- Revenue of $457,000; gross profit $269K at 59% margin.
- Net loss $19.5M (vs $23.6M Q1 2023); adjusted EBITDA -$20.5M.
- Full commercial launch of Platinum instrument started end of March 2024.
- Version 3 sequencing kit on track for launch by end of Q3 2024.
- Paula Dowdy added to Board; FY2024 financial guidance reaffirmed.

## SEC filing metadata
- accession: 0001140361-24-025182
- form_type: 8-K
- ticker: QSI
- cik: 0001816431
- company_name: Quantum-Si Inc
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816431/000114036124025182/0001140361-24-025182-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816431/000114036124025182/ef20028707_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-025182
- JSON: https://secwatch.observer/filing/0001140361-24-025182.json
- Plain text: https://secwatch.observer/filing/0001140361-24-025182.txt

## Key facts
- Earnings Releases
  Quantum-Si Inc reported first quarter ended March 31, 2024 results: revenue $457,000, net income -$19.5 million (net loss of $19.5 million). Guidance reaffirmed.
  - Period: first quarter ended March 31, 2024
  - Revenue: $457,000
  - Net income: -$19.5 million (net loss of $19.5 million)
  - Guidance: reaffirmed
  - Result: reported results
  source text: the “Company”), The Protein Sequencing Company TM , today announced financial results for the first quarter ended March 31, 2024. Press Release Highlights ● Reported revenue of $457,000 in the first quarter of 2024 ● Commenced its full commercial launch of its Platinum ® instrument at the end of March 2024 ● On track to launch version 3 of its sequencing kit,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816431/000114036124025182/0001140361-24-025182-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.